Molecular Endocrinology, Vol 8, 1193-1207, Copyright © 1994 by Endocrine Society

ARTICLES

Novel estrogen response elements identified by genetic selection in yeast are differentially responsive to estrogens and antiestrogens in mammalian cells

SL Dana, PA Hoener, DA Wheeler, CB Lawrence and DP McDonnell
Department of Molecular Biology, Ligand Pharmaceuticals Inc., San Diego, California 92121.

A powerful and versatile system for the identification of novel response elements for members of the intracellular receptor family is presented as applied to the human estrogen receptor. In the past, a limited number of estrogen response elements (EREs) have been functionally identified in the promoter regions of estrogen-regulated genes. From these a consensus ERE has been defined that is identical to the ERE of the Xenopus laevis vitellogenin gene, i.e., 5'-GGTCA NNN TGACC-3'. In order to investigate without bias the range of sequences that could function as EREs in vivo, we have developed a genetic selection in yeast expressing the human estrogen receptor (hER) and transformed with a random oligonucleotide library in a vector where expression of a selectable marker requires insertion of an upstream activating sequence. More than 1,000,000 transformants were screened and of 726 clones that contained activating sequences, 65 were found to be hormone-dependent. Sequencing revealed that the majority contained at least one 4/5 match to a canonical ERE half-site, but only one contained a full consensus ERE as previously defined. Some contained half-sites arranged as direct repeats. Twelve elements were further characterized to compare estrogen activation in yeast and mammalian cells and in vitro binding to hER. The results of these studies reveal that sequences that bind weakly to hER in vitro are fully functional as EREs in yeast and are conditionally responsive to estrogen in mammalian cells. In addition, an element was identified that is more sensitive to the partial agonist activities of tamoxifen and nafoxidine than is the consensus ERE, indicating that not only promoter context but the sequence of the binding site itself can allow distinction between receptor activated by agonist and that activated by antagonist.

This article has been cited by other articles:

				T. M Schaefer, J. A. Wright, P. A. Pioli, and C. R. Wira IL-1{beta}-Mediated Proinflammatory Responses Are Inhibited by Estradiol via Down-Regulation of IL-1 Receptor Type I in Uterine Epithelial Cells J. Immunol., November 15, 2005; 175(10): 6509 - 6516. [Abstract] [Full Text] [PDF]

				D. Das, R. C. Peterson, and W. M. Scovell High Mobility Group B Proteins Facilitate Strong Estrogen Receptor Binding to Classical and Half-Site Estrogen Response Elements and Relax Binding Selectivity Mol. Endocrinol., November 1, 2004; 18(11): 2616 - 2632. [Abstract] [Full Text] [PDF]

				J. M. Hall and K. S. Korach Analysis of the Molecular Mechanisms of Human Estrogen Receptors alpha and beta Reveals Differential Specificity in Target Promoter Regulation by Xenoestrogens J. Biol. Chem., November 8, 2002; 277(46): 44455 - 44461. [Abstract] [Full Text] [PDF]

				C. Lethimonier, G. Flouriot, O. Kah, and B. Ducouret The Glucocorticoid Receptor Represses the Positive Autoregulation of the Trout Estrogen Receptor Gene by Preventing the Enhancer Effect of a C/EBP{beta}-Like Protein Endocrinology, August 1, 2002; 143(8): 2961 - 2974. [Abstract] [Full Text] [PDF]

				H.-J. Huang, J. D. Norris, and D. P. McDonnell Identification of a Negative Regulatory Surface within Estrogen Receptor {alpha} Provides Evidence in Support of a Role for Corepressors in Regulating Cellular Responses to Agonists and Antagonists Mol. Endocrinol., August 1, 2002; 16(8): 1778 - 1792. [Abstract] [Full Text] [PDF]

				J. M. Hall, D. P. McDonnell, and K. S. Korach Allosteric Regulation of Estrogen Receptor Structure, Function, and Coactivator Recruitment by Different Estrogen Response Elements Mol. Endocrinol., March 1, 2002; 16(3): 469 - 486. [Abstract] [Full Text] [PDF]

				S. A. Krieg, A. J. Krieg, and D. J. Shapiro A Unique Downstream Estrogen Responsive Unit Mediates Estrogen Induction of Proteinase Inhibitor-9, a Cellular Inhibitor of IL-1{beta}- Converting Enzyme (Caspase 1) Mol. Endocrinol., November 1, 2001; 15(11): 1971 - 1982. [Abstract] [Full Text] [PDF]

				C. M. Klinge Estrogen receptor interaction with estrogen response elements Nucleic Acids Res., July 15, 2001; 29(14): 2905 - 2919. [Abstract] [Full Text] [PDF]

				P. H. Giangrande, E. A. Kimbrel, D. P. Edwards, and D. P. McDonnell The Opposing Transcriptional Activities of the Two Isoforms of the Human Progesterone Receptor Are Due to Differential Cofactor Binding Mol. Cell. Biol., May 1, 2000; 20(9): 3102 - 3115. [Abstract] [Full Text]

				A. L. Wijayaratne, S. C. Nagel, L. A. Paige, D. J. Christensen, J. D. Norris, D. M. Fowlkes, and D. P. McDonnell Comparative Analyses of Mechanistic Differences Among Antiestrogens Endocrinology, December 1, 1999; 140(12): 5828 - 5840. [Abstract] [Full Text]

				M. E. Cardenas, M. C. Cruz, M. Del Poeta, N. Chung, J. R. Perfect, and J. Heitman Antifungal Activities of Antineoplastic Agents: Saccharomyces cerevisiae as a Model System To Study Drug Action Clin. Microbiol. Rev., October 1, 1999; 12(4): 583 - 611. [Abstract] [Full Text] [PDF]

				J. D. Norris, L. A. Paige, D. J. Christensen, C. Chang, M. R. Huacani, D. Fan, P. T. Hamilton, D. M. Fowlkes, and D. P. McDonnell Peptide Antagonists of the Human Estrogen Receptor Science, July 30, 1999; 285(5428): 744 - 746. [Abstract] [Full Text]

				V. C. Jordan and M. Morrow Tamoxifen, Raloxifene, and the Prevention of Breast Cancer Endocr. Rev., June 1, 1999; 20(3): 253 - 278. [Abstract] [Full Text]

				B. L. Wagner, G. Pollio, P. Giangrande, J. C. Webster, M. Breslin, D. E. Mais, C. E. Cook, W. V. Vedeckis, J. A. Cidlowski, and D. P. McDonnell The Novel Progesterone Receptor Antagonists RTI 3021-012 and RTI 3021-022 Exhibit Complex Glucocorticoid Receptor Antagonist Activities: Implications for the Development of Dissociated Antiprogestins Endocrinology, March 1, 1999; 140(3): 1449 - 1458. [Abstract] [Full Text]

				J. I. Macgregor and V. C. Jordan Basic Guide to the Mechanisms of Antiestrogen Action Pharmacol. Rev., June 1, 1998; 50(2): 151 - 196. [Abstract] [Full Text] [PDF]

				J. D. Norris, D. Fan, M. R. Stallcup, and D. P. McDonnell Enhancement of Estrogen Receptor Transcriptional Activity by the Coactivator GRIP-1 Highlights the Role of Activation Function 2 in Determining Estrogen Receptor Pharmacology J. Biol. Chem., March 20, 1998; 273(12): 6679 - 6688. [Abstract] [Full Text] [PDF]

				P. H. Giangrande, G. Pollio, and D. P. McDonnell Mapping and Characterization of the Functional Domains Responsible for the Differential Activity of the A and B Isoforms of the Human Progesterone Receptor J. Biol. Chem., December 26, 1997; 272(52): 32889 - 32900. [Abstract] [Full Text] [PDF]

				T. M. Willson, J. D. Norris, B. L. Wagner, I. Asplin, P. Baer, H. R. Brown, S. A. Jones, B. Henke, H. Sauls, S. Wolfe, et al. Dissection of the Molecular Mechanism of Action of GW5638, a Novel Estrogen Receptor Ligand, Provides Insights into the Role of Estrogen Receptor in Bone Endocrinology, September 1, 1997; 138(9): 3901 - 3911. [Abstract] [Full Text] [PDF]

				K. Pettersson, K. Grandien, G. G. J. M. Kuiper, and J.-A. Gustafsson Mouse Estrogen Receptor {beta} Forms Estrogen Response Element-Binding Heterodimers with Estrogen Receptor {alpha} Mol. Endocrinol., September 1, 1997; 11(10): 1486 - 1496. [Abstract] [Full Text]

				J. D. Norris, D. Fan, S. A. Kerner, and D. P. McDonnell Identification of a Third Autonomous Activation Domain within the Human Estrogen Receptor Mol. Endocrinol., June 1, 1997; 11(6): 747 - 754. [Abstract] [Full Text]

				J. D. Fraser, D. Keller, V. Martinez, D. Santiso-Mere, R. Straney, and M. R. Briggs Utilization of Recombinant Adenovirus and Dominant Negative Mutants to Characterize Hepatocyte Nuclear Factor 4-regulated Apolipoprotein AI and CIII Expression J. Biol. Chem., May 23, 1997; 272(21): 13892 - 13898. [Abstract] [Full Text] [PDF]

				J. P. Aumais, H. S. Lee, C. DeGannes, J. Horsford, and J. H. White Function of Directly Repeated Half-sites as Response Elements for Steroid Hormone Receptors J. Biol. Chem., May 24, 1996; 271(21): 12568 - 12577. [Abstract] [Full Text] [PDF]

				J. Norris, D. Fan, C. Aleman, J. R. Marks, P. A. Futreal, R. W. Wiseman, J. D. Iglehart, P. L. Deininger, and D. P. McDonnell Identification of a New Subclass of Alu DNA Repeats Which Can Function as Estrogen Receptor-dependent Transcriptional Enhancers J. Biol. Chem., September 29, 1995; 270(39): 22777 - 22782. [Abstract] [Full Text] [PDF]

				S. M. Hyder, Z. Nawaz, C. Chiappetta, K. Yokoyama, and G. M. Stancel The Protooncogene c- jun Contains an Unusual Estrogen-inducible Enhancer within the Coding Sequence J. Biol. Chem., April 14, 1995; 270(15): 8506 - 8513. [Abstract] [Full Text] [PDF]

				L. Jow and R. Mukherjee The Human Peroxisome Proliferator-activated Receptor (PPAR) Subtype NUC1 Represses the Activation of hPPARalpha and Thyroid Hormone Receptors J. Biol. Chem., February 24, 1995; 270(8): 3836 - 3840. [Abstract] [Full Text] [PDF]

				A. L. Wijayaratne and D. P. McDonnell The Human Estrogen Receptor-alpha Is a Ubiquitinated Protein Whose Stability Is Affected Differentially by Agonists, Antagonists, and Selective Estrogen Receptor Modulators J. Biol. Chem., September 14, 2001; 276(38): 35684 - 35692. [Abstract] [Full Text] [PDF]